Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways

Journal of Surgical Research

Volumn 185, Issue 1, 2013, Pages 300-309

  Liu, Fang ^a   Sun, Guo Quan ^b   Gao, Hua Yi ^a   Li, Rui Sheng ^c   Soromou, Lanan Wassy ^d   Chen, Na ^a   Deng, Yan Hong ^a   Feng, Hai Hua ^a  

^a JILIN UNIVERSITY   (China)

^b INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

^c BEIJING 302 HOSPITAL   (China)

^d Institut Supérieur des Sciences et de Médicine Vétérinaire de Dalaba   (Guinea)

Author keywords

Angelicin; Cytokines; Lipopolysaccharide; MAPK; NF B

Indexed keywords

ANGELICIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANGELICIN; CYTOKINES; LIPOPOLYSACCHARIDE; MAPK; NF-ΚB;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; NF-KAPPA B; PNEUMONIA; PSORALENS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886729764     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.05.083     Document Type: Article

References (34)

1. G.D. Rubenfeld, E. Caldwell, and E. Peabody Incidence and outcomes of acute lung injury N Engl J Med 353 2005 1685
2. L. Touqui, and L. Arbibe A role for phospholipase A2 in ARDS pathogenesis Mol Med Today 5 1999 244
3. National Organization for Rare Disorders home page. http://www. rarediseases.org; 2005 [Accessed 23.09.2005].
4. B.G. Garber, P.C. Hebert, J.D. Yelle, R.V. Hodder, and J. McGowan Adult respiratory distress syndrome: a systemic overview of incidence and risk factors Crit Care Med 24 1996 687
5. K. Atabai, and M.A. Matthay The pulmonary physician in critical care. 5: acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology Thorax 57 2002 452
6. M.A. Matthay, G.A. Zimmerman, and C. Esmon Future research directions in acute lung injury Am J Respir Crit Care Med 167 2003 1027
7. R. Yang, L. Yang, and X. Shen Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice Eur J Pharmacol 674 2012 391
8. R.A. Stockley The role of proteinases in the pathogenesis of chronic bronchitis Am J Respir Crit Care Med 150 1994 109
9. T.J. Venaille, G. Ryan, and B.W. Robinson Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum Respir Med 92 1998 233
10. R. Di, M.T. Huang, and C.T. Ho Anti-inflammatory activities of mogrosides from Momor-dica grosvenori in murine macrophages and a murine ear edema model J Agric Food Chem 59 2011 7474
11. H.Y. Song, J.A. Lee, and S.M. Ju Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice Biochem Pharmacol 75 2008 1348
12. S. Sardari, Y. Mori, K. Horita, R.G. Micetich, S. Nishibe, and M. Daneshtalab Synthesis and antifungal activity of coumarins and angular furanocoumarins Bioorg Med Chem 7 1999 1097
13. J. Guo, H. Wu, X. Weng, J. Yan, and K. Bi Studies on extraction and isolation of active constituents from Psoralen corylifolia L. and the antitumor effect of the constituents in vitro Zhong Yao Cai 26 2003 185
14. G.K. Patnaik, K.K. Banaudha, K.A. Khan, A. Shoeb, and B.N. Dhawan Spasmolytic activity of angelicin: a coumarin from Heracleum thomsoni Planta Med 53 1987 517
15. E. Abraham Neutrophils and acute lung injury Crit Care Med 31 2003 195
16. C. Asti, V. Ruggieri, S. Porzio, R. Chiusaroli, G. Melillo, and G.F. Caselli Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage Pulm Pharmacol Ther 13 2000 61
17. L.D. Hudson, J.A. Milberg, and D. Anardi Clinical risks for development of the acute respiratory distress syndrome Am J Respir Crit Care Med 151 1995 293
18. X. Zhang, H. Huang, and T. Yang Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury Injury 41 2010 746
19. K.R. Kim, E.W. Son, D.K. Hee, and S. Pyo The immunomodulatory effects of the herbicide simazine on murine macrophage functions in vitro Toxicol In Vitro 16 2002 517
20. Y.L. Yang, J.P. Li, and K.Z. Li Tumor necrosis factor alpha antibody prevents brain damage of rats with acute necrotizing pancreatitis World J Gastroenterol 10 2004 2898
21. C.F. Jiang, Y.C. Shiau, and K.W. Ng Serum interleukin-6 tumor necrosis factor alpha and C-reactive protein in early prediction of severity of acute pancreatitis J Chin Med Assoc 67 2004 442
22. M.W. Johansson, M. Patarroyo, F. Oberg, A. Siegbahn, and K. Nilson Myeloperoxidase mediates cell adhesion via the alpha Mbeta 2 integrin (Mac-1, CD11b/CD18) J Cell Sci 110 1997 1133
23. M. Bhatia, and S. Moochhala Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome J Pathol 202 2004 145
24. S.C. Donnelly, C. Haslett, P.T. Reid, I.S. Grant, W.A. Wallace, and C.N. Metz Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome Nat Med 3 1997 320
25. T. Minamino, and I. Komuro Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury J Clin Invest 116 2006 2316
26. C.J. Sanderson Interleukin-5, eosinophils, and disease Blood 79 1992 3101
27. P. Tak, and G. Firestein NF-kappaB: a key role in inflammatory diseases J Clin Invest 107 2001 7
28. J. Fan, R.D. Ye, and A.B. Malik Transcriptional mechanisms of acute lung injury Am J Physiol Lung Cell Mol Physiol 281 2001 1037
29. M.Y. Kuo, M.F. Liao, and F.L. Chen Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFκB pathways in mice with endotoxin-induced acute lung injury Food Chem Toxicol 49 2011 2660
30. O. Prause, A. Bossios, E. Silverpil, S. Ivanov, S. Bozinovski, and R. Vlahos IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo - effects of anti-inflammatory pharmacotherapy Pulm Pharmacol Ther 3 2009 199
31. P. Moine, R. McIntyre, and M.D. Schwartz NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome Shock 13 2000 85
32. B. Kaminska MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits Biochem Biophys Acta 1754 2005 253
33. G.Y. Song, C.S. Chung, I.H. Chaudry, and A. Ayala MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis Am J Physiol Cell Physiol 281 2001 662
34. K. Schuh, and A. Pahl Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury Biochem Pharmacol 77 2009 1827